Zhongshan Cheng1, Hang Zhou1, Richard Sherva2, Lindsay A Farrer2, Henry R Kranzler3, Joel Gelernter4. 1. Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Massachusetts; VA Connecticut Healthcare Center, West Haven, Massachusetts. 2. Departments of Neurology, Ophthalmology, Genetics & Genomics, Epidemiology, and Biostatistics, Boston University School of Medicine and School Public Health, Boston, Massachusetts. 3. Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania. 4. Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Massachusetts; Departments of Genetics and Neuroscience, Yale University School of Medicine, New Haven, Massachusetts; VA Connecticut Healthcare Center, West Haven, Massachusetts. Electronic address: joel.gelernter@yale.edu.
Abstract
BACKGROUND: Opioid dependence (OD) is at epidemic levels in the United States. Genetic studies can provide insight into its biology. METHODS: We completed an OD genome-wide association study in 3058 opioid-exposed European Americans, 1290 of whom met criteria for a DSM-IV diagnosis of OD. Analysis used DSM-IV criterion count. RESULTS: By meta-analysis of four cohorts, Yale-Penn 1 (n = 1388), Yale-Penn 2 (n = 996), Yale-Penn 3 (n = 98), and SAGE (Study of Addiction: Genetics and Environment) (n = 576), we identified a variant on chromosome 15, rs12442183, near RGMA, associated with OD (p = 1.3 × 10-8). The association was also genome-wide significant in Yale-Penn 1 taken individually and nominally significant in two of the other three samples. The finding was further supported in a meta-analysis of all available opioid-exposed African Americans (n = 2014 [1106 meeting DSM-IV OD criteria]; p = 3.0 × 10-3) from three cohorts; there was nominal significance in two of these samples. Thus, of seven subsamples examined in two populations, one was genome-wide significant, and four of six were nominally (or nearly) significant. RGMA encodes repulsive guidance molecule A, which is a central nervous system axon guidance protein. Risk allele rs12442183*T was correlated with higher expression of a specific RGMA transcript variant in frontal cortex (p = 2 × 10-3). After chronic morphine injection, the homologous mouse gene (Rgma) was upregulated in C57BL/6J striatum. Coexpression analysis of 1301 brain samples revealed that RGMA messenger RNA expression was associated with that of four genes implicated in other psychiatric disorders, including GRIN1. CONCLUSIONS: This is the first study to demonstrate an association of RGMA with OD. It provides a new lead into our understanding of OD pathophysiology.
BACKGROUND:Opioid dependence (OD) is at epidemic levels in the United States. Genetic studies can provide insight into its biology. METHODS: We completed an OD genome-wide association study in 3058 opioid-exposed European Americans, 1290 of whom met criteria for a DSM-IV diagnosis of OD. Analysis used DSM-IV criterion count. RESULTS: By meta-analysis of four cohorts, Yale-Penn 1 (n = 1388), Yale-Penn 2 (n = 996), Yale-Penn 3 (n = 98), and SAGE (Study of Addiction: Genetics and Environment) (n = 576), we identified a variant on chromosome 15, rs12442183, near RGMA, associated with OD (p = 1.3 × 10-8). The association was also genome-wide significant in Yale-Penn 1 taken individually and nominally significant in two of the other three samples. The finding was further supported in a meta-analysis of all available opioid-exposed African Americans (n = 2014 [1106 meeting DSM-IV OD criteria]; p = 3.0 × 10-3) from three cohorts; there was nominal significance in two of these samples. Thus, of seven subsamples examined in two populations, one was genome-wide significant, and four of six were nominally (or nearly) significant. RGMA encodes repulsive guidance molecule A, which is a central nervous system axon guidance protein. Risk allele rs12442183*T was correlated with higher expression of a specific RGMA transcript variant in frontal cortex (p = 2 × 10-3). After chronic morphine injection, the homologous mouse gene (Rgma) was upregulated in C57BL/6J striatum. Coexpression analysis of 1301 brain samples revealed that RGMA messenger RNA expression was associated with that of four genes implicated in other psychiatric disorders, including GRIN1. CONCLUSIONS: This is the first study to demonstrate an association of RGMA with OD. It provides a new lead into our understanding of OD pathophysiology.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: E Mundo; S Tharmalingham; M Neves-Pereira; E J Dalton; F Macciardi; S V Parikh; A Bolonna; R W Kerwin; M J Arranz; A J Makoff; J L Kennedy Journal: Mol Psychiatry Date: 2003-02 Impact factor: 15.992
Authors: A C Pereira; J D Gray; J F Kogan; R L Davidson; T G Rubin; M Okamoto; J H Morrison; B S McEwen Journal: Mol Psychiatry Date: 2016-03-29 Impact factor: 15.992
Authors: Adaikalavan Ramasamy; Daniah Trabzuni; Sebastian Guelfi; Vibin Varghese; Colin Smith; Robert Walker; Tisham De; Lachlan Coin; Rohan de Silva; Mark R Cookson; Andrew B Singleton; John Hardy; Mina Ryten; Michael E Weale Journal: Nat Neurosci Date: 2014-08-31 Impact factor: 24.884
Authors: Rachel L Kember; Rachel Vickers-Smith; Heng Xu; Sylvanus Toikumo; Maria Niarchou; Hang Zhou; Emily E Hartwell; Richard C Crist; Christopher T Rentsch; Lea K Davis; Amy C Justice; Sandra Sanchez-Roige; Kyle M Kampman; Joel Gelernter; Henry R Kranzler Journal: Nat Neurosci Date: 2022-09-28 Impact factor: 28.771
Authors: Richard Sherva; Congcong Zhu; Leah Wetherill; Howard J Edenberg; Emma Johnson; Louisa Degenhardt; Arpana Agrawal; Nicholas G Martin; Elliot Nelson; Henry R Kranzler; Joel Gelernter; Lindsay A Farrer Journal: Explor Med Date: 2021-02-28
Authors: Renato Polimanti; Raymond K Walters; Emma C Johnson; Jeanette N McClintick; Amy E Adkins; Daniel E Adkins; Silviu-Alin Bacanu; Laura J Bierut; Tim B Bigdeli; Sandra Brown; Kathleen K Bucholz; William E Copeland; E Jane Costello; Louisa Degenhardt; Lindsay A Farrer; Tatiana M Foroud; Louis Fox; Alison M Goate; Richard Grucza; Laura M Hack; Dana B Hancock; Sarah M Hartz; Andrew C Heath; John K Hewitt; Christian J Hopfer; Eric O Johnson; Kenneth S Kendler; Henry R Kranzler; Kenneth Krauter; Dongbing Lai; Pamela A F Madden; Nicholas G Martin; Hermine H Maes; Elliot C Nelson; Roseann E Peterson; Bernice Porjesz; Brien P Riley; Nancy Saccone; Michael Stallings; Tamara L Wall; Bradley T Webb; Leah Wetherill; Howard J Edenberg; Arpana Agrawal; Joel Gelernter Journal: Mol Psychiatry Date: 2020-02-26 Impact factor: 15.992